PT Biometrik Riset Indonesia Appointed as CRO for Uremic Clearance Granules (UCG) Clinical Trial, Marking Milestone in Indonesia–China Research Collaboration

Jakarta, October 15, 2026 – PT Biometrik Riset Indonesia, an independent Contract Research Organization (CRO) specializing in clinical research and Bioequivalence (BE) studies, plays a key role in overseeing the clinical trial of Uremic Clearance Granules (UCG), a Traditional Chinese Medicine (TCM) product, officially launched at RSPAD Gatot Soebroto Puskesad, Jakarta, on October 15, 2026.

This clinical trial represents an important milestone in international clinical research collaboration between Indonesia and China, bringing together PT Intrada Subur Abadi (Indonesia), Consun Pharmaceutical (China), and RSPAD Gatot Soebroto Puskesad Jakarta. As the appointed CRO, PT Biometrik Riset Indonesia is responsible for supporting and overseeing the clinical trial to ensure its implementation in accordance with the study protocol, Good Clinical Practice (GCP), research ethics, and applicable regulatory requirements.

The study aims to evaluate the efficacy and safety of UCG as an adjunctive therapy to standard treatment in patients with Stage 3–4 Chronic Kidney Disease (CKD), with an estimated glomerular filtration rate (eGFR) of 15–60 mL/min/1.73 m².

Designed as a multicenter, randomized, double-blind, placebo-controlled study, the trial will involve 100 subjects across two clinical research sites: RSPAD Gatot Soebroto Puskesad in Jakarta and RSUP Dr. Kariadi in Semarang.

PT Biometrik Riset Indonesia: Supporting Quality and Excellence in Clinical Research

As the appointed Contract Research Organization, PT Biometrik Riset Indonesia contributes to the coordination and oversight of the clinical trial, supporting the study's implementation while upholding the principles of Good Clinical Practice (GCP), research ethics, and applicable Indonesian regulatory standards.

The involvement of Biometrik in this international study reflects its continued commitment to delivering reliable clinical research services and supporting collaborations between pharmaceutical companies, healthcare institutions, and international research partners.

Through its role in this study, Biometrik continues to contribute to the development of Indonesia's clinical research capabilities and the advancement of high-quality clinical trials in the country